Mitochondrial energy metabolism and redox responses to hypertriglyceridemia.
In this work we review recent findings that explain how mitochondrial bioenergetic functions and redox state respond to a hyperlipidemic in vivo environment and may contribute to the maintenance of a normal metabolic phenotype. The experimental model utilized to evidence these adaptive mechanisms is especially useful for these studies since it exhibits genetic hypertriglyceridemia and avoids complications introduced by high fat diets. Liver from hypertrigliceridemic (HTG) mice have a greater content of glycerolipids together with increased mitochondrial free fatty acid oxidation. HTG liver mitochondria have a higher resting respiration rate but normal oxidative phosphorylation efficiency. This is achieved by higher activity of the mitochondrial potassium channel sensitive to ATP (mitoK(ATP)). The mild uncoupling mediated by mitoK(ATP) accelerates respiration rates and reduces reactive oxygen species generation. Although this response is not sufficient to inhibit lipid induced extra-mitochondrial oxidative stress in whole liver cells it avoids amplification of this redox imbalance. Furthermore, higher mitoK(ATP) activity increases liver, brain and whole body metabolic rates. These mitochondrial adaptations may explain why these HTG mice do not develop insulin resistance and obesity even under a severe hyperlipidemic state. On the contrary, when long term high fat diets are employed, insulin resistance, fatty liver and obesity develop and mitochondrial adaptations are inefficient to counteract energy and redox imbalances.
Departamento de Física e Química, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil. alberici@fcfrp.usp.br
Luciane C
LC
Alberici
Anibal E
AE
Vercesi
Helena C F
HC
Oliveira
D000222:Adaptation, Physiological / Q000502:physiology*; D000818:Animals; D019069:Cell Respiration / Q000502:physiology; D004734:Energy Metabolism / Q000502:physiology*; D015228:Hypertriglyceridemia / Q000378:metabolism*; D054086:KATP Channels / Q000378:metabolism; D008099:Liver / Q000378:metabolism*; D051379:Mice; D008928:Mitochondria / Q000378:metabolism*; D010084:Oxidation-Reduction
D054086:KATP Channels
Free Radic Biol Med. 2008 Aug 1;45(3):231-41
18482593
Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S161-4
17481767
Circ Res. 2001 Dec 7;89(12):1177-83
11739283
Biochem Mol Biol Int. 1997 Jun;42(1):29-34
9192082
Free Radic Biol Med. 2007 Apr 1;42(7):1039-48
17349931
Science. 1990 Aug 17;249(4970):790-3
2167514
Mol Biol Rep. 2010 Oct;37(7):3177-82
19834821
Int J Biochem Cell Biol. 1998 Nov;30(11):1163-8
9839442
Med Hypotheses. 1999 Jan;52(1):15-22
10342665
Arch Biochem Biophys. 2001 May 15;389(2):195-200
11339808
Biochim Biophys Acta. 2000 Aug 15;1459(2-3):383-9
11004454
Exp Gerontol. 2006 Jul;41(7):697-703
16621391
Nature. 2006 Dec 14;444(7121):847-53
17167472
J Bioenerg Biomembr. 2003 Oct;35(5):451-7
14740893
J Lipid Res. 2000 Aug;41(8):1205-13
10946007
FEBS Lett. 1991 Dec 9;294(3):158-62
1756853
Aging Cell. 2005 Jun;4(3):147-55
15924571
FEBS Lett. 1976 Jan 15;61(2):103-110
765149
Nature. 2000 Jul 27;406(6794):415-8
10935638
Adv Exp Med Biol. 1977;78:67-82
197811
Biochim Biophys Acta. 2003 Sep 30;1606(1-3):23-41
14507425
Nature. 2006 Dec 14;444(7121):881-7
17167477
J Clin Invest. 2000 Apr;105(8):1067-75
10772651
Mol Cell Biochem. 1997 Sep;174(1-2):71-8
9309668
J Neurosci Res. 2008 May 15;86(7):1548-56
18189325
Obes Res. 2003 Dec;11(12):1429-43
14694206
Free Radic Biol Med. 2009 Nov 15;47(10):1432-9
19703550
Gastroenterology. 2006 Oct;131(4):1228-34
17030192
J Clin Invest. 1992 Nov;90(5):1889-900
1430212
Proc Nutr Soc. 2004 May;63(2):287-92
15294045
J Lipid Res. 1994 May;35(5):820-4
8071604
Int J Obes (Lond). 2007 Oct;31(10):1586-95
17471296
Mech Ageing Dev. 2000 Jan 24;113(1):37-48
10708248
Circulation. 2004 Jan 27;109(3):433-8
14744958
J Bioenerg Biomembr. 2010 Jun;42(3):245-53
20373005
Horm Metab Res. 2002 Jan;34(1):21-6
11832997
J Clin Invest. 1995 Dec;96(6):2914-23
8675663